Bellevue Group’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$6.63M Sell
2023
Q2
$17.2M Buy
2023
Q1
$17.7M Buy
2022
Q4
$25.1M Buy
2022
Q3
$27.6M Buy
2022
Q2
$18M Sell
2022
Q1
$15.8M Sell
2021
Q4
$25.9M Sell
2021
Q3
$40.2M Buy
2021
Q2
$39.9M Buy
2021
Q1
$46.1M Buy
2020
Q4
$51.3M Buy